The Preclinical Characterization of TST003, a First-in-class Mab Targeting Gremlin-1 Overexpressed by Cancer-Associated Fibroblasts and Tumor Cells
CANCER RESEARCH（2023）
Key words
Cancer Progression
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined